A prospective study on the effectiveness of natrum muriaticum in managing depressive disorder assesses using hamilton depression rating sacle-17
Trial Snapshot
- Phase
- Phase 3 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 34
- Locations
- 1
- Primary Endpoint
- Assessment is done for every 2 weeks medication and the cases is followed up period
Study Overview
Brief Summary
INTRODUCTION: Depressive disorder is one of the most prevalent mental health conditions worldwide, characterized by persistent sadness, loss of interest, and impaired daily functioning. According to the World Health Organization (WHO), depression is a leading cause of disability globally, significantly impacting individuals’ quality of life, productivity, and overall well-being. Natrum muriaticum is frequently prescribed based on the principle of individualization, especially in cases presenting with classical depressive symptoms like grief, sadness, and emotional suppression. The Hamilton Depression Rating Scale - 17 (HAM-D-17) is a validated and widely used clinician-administered questionnaire that assesses the severity of depression. It provides a structured method to
objectively evaluate the effectiveness of interventions aimed at reducing depressive symptoms. PROCEDURE: Patients diagnosed with depressive disorder, as per the ICD-10 criteria, will be assessed using the HAM-D-17 scale. After detailed case taking, Natrum muriaticum will be prescribed based on symptom similarity. At each follow-up visit, the assessment will be repeated using the HAM-D-17 scale. OUTCOME : The effectiveness of Natrum muriaticum will be assessed based on improvement in the Depressive Disorder HAM-D - 17 Scale.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Patients diagnosed with depressive disorder according to ICD-10 criteria. Age group.
- •18 to 65 years. Both genders.
Exclusion Criteria
- •Patients with severe mental illness, currently on antidepressants or other homoeopathic medicines.
- •Pregnant and lactation women Patients under other psychiatric medications.
Outcomes
Primary Outcomes
Assessment is done for every 2 weeks medication and the cases is followed up period
Time Frame: 6months
of 6 months
Time Frame: 6months
Secondary Outcomes
- Assessment is done for every 2 weeks medication and the cases is followed up period(of 6 months)
Investigators
Vishnu Priya
Sarada krishna homoeopathic medical college